| Literature DB >> 31610263 |
Shang-Zhi Zhang1, Jie Wang1, Lin-Bao Zhu1, Shahzad Toufeeq1, Xin Xu1, Ling-Ling You1, Bing Li1, Pei Hu1, Jia-Ping Xu2.
Abstract
Bombyx mori nucleopolyhedrovirus (BmNPV) is a major pathogen causing severe economic loss. Previous studies have revealed that some proteins in silkworm digestive juice show antiviral activity. In this study, antiviral activity examination of different resistant strains showed that the digestive juice of the resistant strain (A35) had higher inhibition to virus than the susceptible strain (P50). Subsequently, the label-free quantitative proteomics was used to study the midgut digestive juice response to BmNPV infection in P50 and A35 strains. A total of 98 proteins were identified, of which 80 were differentially expressed proteins (DEPs) with 54 enzymes and 26 nonenzymatic proteins by comparing the proteomes of infected and non-infected P50 and A35 silkworms. These DEPs are mainly involved in metabolism, proteolysis, neuroactive ligand receptor interaction, starch and sucrose metabolism and glutathione metabolism. After removing the genetic background and individual immune stress response proteins, 9 DEPs were identified potentially involved in resistance to BmNPV. Further studies showed that a serine protease, an alkaline phosphatase and serine protease inhibitor 2 isoform X1 were differentially expressed in A35 compared to P50 or post BmNPV infection. Taken together, these results provide insights into the potential mechanisms for silkworm digestive juice to provide resistance to BmNPV infection. Signifcance: Bombyx mori nucleopolyhedrovirus (BmNPV) is highly pathogenic, which has a great impact on the sericulture. BmNPV entered the midgut lumen and exposed to digestive juices after oral infection. Previous studies have revealed that some proteins in silkworm digestive juice show antiviral activity, however, current information on the digestive juice proteome of high resistant silkworm strain after BmNPV challenge compared to susceptible strain is incomprehensive. Here, we combined label-free quantification method, bioinformatics, RT-qPCR and western blot analysis and found that BmNPV infection causes some protein changes in the silkworm midgut digestive juice. The DEPs were identified in the digestive juices of different resistant strains following BmNPV infection, and screened out some proteins potentially related to resistance to BmNPV. Three important differentially expression proteins were validated by independent approaches. These findings uncover the potential role of silkworm digestive juice in providing resistance to BmNPV and supplemented the profile of the proteome of the digestive juices in B. mori.Entities:
Keywords: Bombyx mori; Bombyx mori nucleopolyhedrovirus (BmNPV); Digestive juice; Label-free
Mesh:
Substances:
Year: 2019 PMID: 31610263 PMCID: PMC7102787 DOI: 10.1016/j.jprot.2019.103527
Source DB: PubMed Journal: J Proteomics ISSN: 1874-3919 Impact factor: 4.044
Fig. 1The antiviral activity of digestive juice in silkworm. Proliferation of BmNPV was assessed using RT-qPCR by analyzing relative transcription levels of VP39 at 24 h, 48 h and 72 h post infection in the midguts.“P50 + BmNPV”,“A35 + BmNPV”and “BmNPV”indicates P50- digestive juice, A35- digestive juice and ddH2O mixed with BmNPV. There were three biological sample replicates, and each biological sample replicate included three technique replicates.The statistical analysis was conducted using ANOVA and an LSD a posteriori test using SPSS (*** P < .001).
Fig. 2Proteins extracted from silkworm midgut digestive juices were separated by SDS-PAGE. M: protein marker, the plus and minus represent BmNPV-challenged group and control group, respectively. Different bands in the different strain are shown with the black arrows.
Fig. 3The distribution of total proteins. (A) Summary of total digestive juice proteins identified by a Label-free by approach in four groups. The numbers indicate the quantity of proteins that were expressed in each group. (B) Venn analysis of total digestive juice proteins in the four groups. The numbers and percentages denote the amount and ratio of proteins that were expressed in each group, respectively. Purple indicates P50-; yellow indicates P50+; green indicates A35- and pink indicates A35+. The red circle indicates the number of proteins only expressed in each unique group, and the black circle indicates the number of proteins expressed in all groups. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 4The distribution of differentially expressed proteins. (A) Summary of DEPs in four groups. The numbers denote the number of proteins that were expressed in each group. (B) Venn analysis of DEPs in the four groups. The numbers denote the number of proteins that were expressed in each group. Blue indicates P50+ vs P50-; pink indicates A35+ vs P50+; yellow indicates A35+ vs A35-; and green indicates A35- vs P50-. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 5Gene ontology (GO) analysis of DEPs between each group. Functional assignments if proteins their corresponding associated biological processes, molecular function and cellular components are shown. The percentage of DEPs that could be assigned to the different categories was indicated.
Fig. 6KEGG enrichment analysis of DEPs. To the left of each plot are KEGG terms. Under each plot the number proteins are shown.
Differentially expressed Enzymes proteins in different resistant strain following BmNPV infection.
| Protein ID | Protein description | Accession | A35+ vs. P50+ ratio | A35- vs. P50- ratio | A35+ vs. A35- ratio | P50+ vs. P50- ratio |
|---|---|---|---|---|---|---|
| Bm_nscaf2674_066 | trypsin alkaline A-like protein, partial [ | APS85762 | 780.424 | 3186.616 | NS | NS |
| Bm_scaffold644_4 | collagenase [ | XP_004927691 | 11.067 | 8.279 | 1.554 | NS |
| Bm_nscaf2983_048 | trypsin, alkaline A [ | XP_004923290 | 5.134 | 3.897 | NS | NS |
| Bm_nscaf2902_287 | chymotrypsin-like serine protease precursor [ | NP_001040430 | 3.04 | 5.172 | NS | NS |
| Bm_scaffold769_2 | serine protease precursor [ | NP_001036826 | 2.785 | 2.98 | NS | NS |
| Bm_nscaf2674_017 | LOW QUALITY PROTEIN: trypsin, alkaline C [ | XP_012549322 | 2.449 | 2.367 | NS | NS |
| Bm_scaffold644_3 | serine protease [ | AAX39409 | 2.326 | 2.169 | 2.108 | NS |
| Bm_nscaf2674_063 | trypsin, alkaline C [ | XP_004930040 | 2.29 | NS | 2.552 | NS |
| Bm_nscaf3058_335 | collagenase-like [ | XP_013167497 | 2.128 | 1.768 | NS | NS |
| Bm_nscaf2993_279 | trypsin, alkaline C [ | XP_004929525 | 2.091 | 1.674 | NS | NS |
| Bm_nscaf2902_225 | LOW QUALITY PROTEIN: transmembrane protease serine 9-like [ | XP_021201549 | 1.787 | NS | 1.547 | NS |
| Bm_nscaf3058_362 | brachyurin [ | XP_004928997 | 1.734 | 1.572 | NS | NS |
| Bm_nscaf1962_13 | trypsin alpha-3 [ | XP_004927140 | 1.658 | 1.723 | NS | NS |
| Bm_nscaf2902_226 | chymotrypsin-like protease C8 [ | ABR88238 | 1.533 | NS | NS | NS |
| Bm_nscaf2983_050 | trypsin-like serine protease [ | NP_001243950 | 0.611 | NS | 2.061 | NS |
| Bm_nscaf2901_48 | ovochymase-2 [ | XP_021203513 | 0.61 | 0.521 | NS | NS |
| Bm_nscaf3058_328 | 35 kDa protease precursor [ | NP_001037037 | 0.58 | NS | NS | NS |
| Bm_nscaf3058_337 | serine protease 3 [ | XP_004928982 | 0.431 | 0.533 | NS | NS |
| Bm_nscaf2953_114 | collagenase isoform X1 [ | XP_004922848 | A35+ | A35- | NS | N |
| Bm_nscaf3058_329 | collagenase- partial [ | XP_004928979 | A35+ | A35- | NS | N |
| Bm_nscaf3058_338 | collagenase [ | XP_004928983 | A35+ | A35- | NS | N |
| Bm_scaffold644_6 | collagenase [ | XP_004927692 | A35+ | A35- | 2.579 | N |
| Bm_nscaf2674_064 | trypsin, alkaline C [ | XP_004930042 | A35+ | A35- | NS | N |
| Bm_scaffold644_5 | serine protease precursor [ | NP_001036903 | A35+ | A35- | NS | N |
| Bm_nscaf2795_043 | venom serine protease [ | XP_004922529 | A35+ | N | A35+ | N |
| Bm_nscaf2883_014 | collagenase [ | XP_004923933 | P50+ | P50- | N | NS |
| Bm_nscaf2983_046 | trypsin, alkaline C [ | XP_004923288 | P50+ | P50- | N | NS |
| Bm_nscaf2986_178 | trypsin, alkaline A [ | XP_004931376 | NS | A35- | 0.654 | P50+ |
| Bm_nscaf2983_049 | trypsin-like protease precursor [ | NP_001093273 | NS | NS | 1.705 | NS |
| Bm_nscaf2529_051 | lipase member H-A [ | XP_004932346 | 9.716 | 4.164 | 3.025 | NS |
| Bm_nscaf3032_110 | pancreatic triacylglycerol lipase [ | XP_004924199 | P50+ | P50- | N | NS |
| Bm_nscaf2889_046 | aminopeptidase N [ | AAC33301 | 0.373 | NS | 0.599 | NS |
| Bm_nscaf2889_049 | membrane alanyl aminopeptidase [ | XP_021208930 | NS | A35- | NS | P50+ |
| Bm_nscaf2889_053 | aminopeptidase N-7 [ | AFK85023 | 0.039 | P50- | A35+ | NS |
| Bm_nscaf2953_014 | carboxypeptidase B-like precursor [ | NP_001296550 | 4.23 | 3.55 | NS | NS |
| Bm_nscaf2818_010 | carboxypeptidase B [ | XP_004923345 | 3.481 | 3.155 | NS | NS |
| Bm_nscaf2818_078 | zinc carboxypeptidase [ | XP_012553139 | A35+ | A35- | NS | N |
| Bm_nscaf3098_76 | carboxylesterase CarE-7 [ | ABY57298 | A35+ | A35- | NS | N |
| Bm_nscaf2575_105 | esterase FE4 [ | XP_021208942 | A35+ | A35- | NS | N |
| Bm_nscaf2953_011 | zinc carboxypeptidase [ | XP_021208707 | NS | A35- | NS | P50+ |
| Bm_nscaf1898_224 | akaline nuclease precursor [ | NP_001091744 | 2.496 | NS | NS | NS |
| Bm_nscaf1681_013 | beta-1,3-glucanase [ | ACU57045 | 1.567 | 1.625 | NS | NS |
| Bm_nscaf1898_444 | venom dipeptidyl peptidase 4 [ | XP_021204723 | 0.639 | NS | NS | NS |
| Bm_scaffold416_08 | prostatic acid phosphatase [ | XP_012546808 | 0.598 | NS | NS | NS |
| Bm_nscaf2925_05 | alkaline phosphatase [ | BAG41975 | 0.401 | 0.361 | NS | NS |
| Bm_nscaf2827_48 | alpha-amylase precursor [ | NP_001166624 | 0.0004 | P50- | A35+ | NS |
| Bm_nscaf3058_115 | apyrase [ | XP_004928875 | A35+ | N | A35+ | N |
| Bm_nscaf2818_054 | XP_021208662 | A35+ | A35- | NS | N | |
| Bm_nscaf3097_36 | chitin deacetylase 5b [ | ADB43612 | P50+ | P50- | N | NS |
| Bm_nscaf1289_1 | chitinase isoform 3 precursor [ | NP_001166832 | P50+ | N | N | P50+ |
| Bm_nscaf2838_097 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] [ | XP_012543884 | P50+ | N | N | P50+ |
| Bm_nscaf3056_04 | peroxidase [ | XP_012545623 | N | A35- | A35- | N |
| Bm_nscaf1681_231 | peroxidase isoform X1 [ | XP_012550815 | N | A35- | A35- | N |
| Bm_nscaf2818_052 | XP_004923368 | N | N | A35+ | N | |
NS: non-significant protein in comparable group, N: no expressed protein in comparable group, P50-, P50+, A35- and A35+: the protein only expressed in P50-, P50+, A35- and A35+ group.
DEPs by label-free associated with immunity in silkworm in different resistant strain after BmNPV infection.
| Protein ID | Protein description | Accession | A35 + _vs_P50+ ratio | A35-_vs_P50- ratio | A35 + _vs_A35- ratio | P50 + _vs_P50- ratio |
|---|---|---|---|---|---|---|
| Bm_nscaf2888_098 | serine protease inhibitor 2 isoform X1 [ | XP_012547756 | 0.224 | 0.587 | 0.428 | NS |
| Bm_nscaf2979_2 | antitrypsin isoform X1 [ | XP_021204540 | 0.293 | 0.281 | 0.579 | NS |
| Bm_nscaf2641_2 | serine protease inhibitor 16 precursor [ | NP_001139708 | P50+ | P50- | N | NS |
| Bm_nscaf3058_130 | peptidoglycan recognition protein precursor [ | NP_001243949 | 0.463 | NS | NS | NS |
NS: non-significant protein in comparable group, N: no expressed protein in comparable group, P50-, P50+, A35- and A35+: the protein only expressed in P50-, P50+, A35- and A35+ group.
The DEPs potentially related to resistance to BmNPV.
| Protein ID | Protein description | Accession | A35 + _vs_P50+ ratio | A35-_vs_P50- ratio | A35 + _vs_A35- ratio | P50 + _vs_P50- ratio |
|---|---|---|---|---|---|---|
| Bm_scaffold1148_1 | uncharacterized protein LOC101744440 [ | KPJ17799 | 8.441 | NS | 3.408 | NS |
| Bm_nscaf2655_107 | uncharacterized protein LOC101735588 [ | XP_021209046 | 3.783 | NS | 2.072 | NS |
| Bm_nscaf2674_063 | trypsin, alkaline C [ | XP_004930040 | 2.290 | NS | 2.552 | NS |
| Bm_nscaf2902_225 | transmembrane protease serine 9-like [ | XP_021201549 | 1.787 | NS | 1.547 | NS |
| Bm_nscaf2983_050 | trypsin-like serine protease [ | NP_001243950 | 0.611 | NS | 2.061 | NS |
| Bm_nscaf2889_046 | aminopeptidase N [ | AAC33301 | 0.373 | NS | 0.599 | NS |
| Bm_nscaf2795_043 | venom serine protease [ | XP_004922529 | A35+ | N | A35+ | N |
| Bm_nscaf2818_052 | XP_004923368 | A35+ | N | A35+ | N | |
| Bm_nscaf3058_115 | apyrase [ | XP_004928875 | A35+ | N | A35+ | N |
NS: non-significant protein in comparable group, N: no expressed protein in comparable group, P50-, P50+, A35- and A35+: the protein only expressed in P50-, P50+, A35- and A35+ group.
Fig. 7Differential expression levels of 9 DEPs corresponding to the co-regulated genes of midgut in both strains of BmNPV-infected and control silkworm larvae at 24 h post inoculation. The y-axis on the left side indicates the expression level of candidate proteins. The x-axis on the right side indicates the relative expression level of candidate gene mRNA transcripts. Data were normalized using BmGADPH and represented as means ± standard errors of the means from three independent experiments. Relative expression levels were calculated using the 2-△△Ct method. Statistical analysis was conducted using the SPSS software. Significant differences are indicated by different letters (p < .05).
Fig. 8Confirmation of three differentially expressed proteins (SP, AP and Spn-2) with Western blotting. A, The protein levels of SP, AP and Spn-2 in P50−, P50+, A35− and A35+. 30 μg each of midgut digestive juice protein was analyzed by western blot with antiserum (top). Total proteins were Coomassie Brilliant Blue (CBB)-stained as the loading control (bottom). B, Label-free results from 3 DEPs in P50 and A35 strains showing BmNPV-infected and control groups. C, Densitometric intensity of the Western blot was analyzed by using Image J software. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)